|
1) Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981; 292: 154-6
|
|
|
|
2) Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A. 1981; 78: 7634-8
|
|
|
|
|
|
3) Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines. derived from human blastocysts. Science. 1998; 282: 1145-7
|
|
|
|
|
|
4) Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126: 663-76
|
|
|
|
|
|
5) Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007; 318: 1917-20
|
|
|
|
|
|
6) Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131: 861-72
|
|
|
|
|
|
7) Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell. 2008; 132: 661-80
|
|
|
|
|
|
8) Saxen L. Organogenesis of the kidney. Cambridge: Cambridge University Press; 1987
|
|
|
|
|
|
9) Mugford JW, Sipilä P, McMahon JA, et al. Osr1 expression demarcates a multi-potent population of intermediate mesoderm that undergoes progressive restriction to an Osr1-dependent nephron progenitor compartment within the mammalian kidney. Dev Biol. 2008; 324: 88-98
|
|
|
|
|
|
10) Osafune K, Takasato M, Kispert A, et al. Identification of multipotent progenitors in the embryonic mouse kidney by a novel colony-forming assay. Development. 2006; 133: 151-61
|
|
|
|
|
|
11) Kobayashi A, Valerius MT, Mugford JW, et al. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell. 2008; 3: 169-81
|
|
|
|
|
|
12) Cheng HT, Kim M, Valerius MT, et al. Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development. 2007; 134: 801-11
|
|
|
|
|
|
13) Asashima M, Ito Y, Chan T, et al. In vitro organogenesis from undifferentiated cells in Xenopus. Dev Dyn. 2009; 238: 1309-20
|
|
|
|
|
|
14) Moriya N, Uchiyama H, Asashima M. Induction of pronephric tubules by activin and retinoic acid in presumptive ectoderm of Xenopus laevis. Dev Growth Differ. 1993; 35: 123-8
|
|
|
|
|
|
15) Brennan HC, Nijjar S, Jones EA. The specification and growth factor inducibility of the pronephric glomus in Xenopus laevis. Development. 1999; 126: 5847-56
|
|
|
|
|
|
16) Osafune K, Nishinakamura R, Komazaki S, et al. In vitro induction of the pronephric duct in Xenopus explants. Dev Growth Differ. 2002; 44: 161-7
|
|
|
|
|
|
17) Kim D, Dressler GR. Nephrogenic factors promote differentiation of mouse embryonic stem cells into renal epithelia. J Am Soc Nephrol. 2005; 16: 3527-34
|
|
|
|
|
|
18) Yamamoto M, Cui L, Johkura K, et al. Branching ducts similar to mesonephric ducts or ureteric buds in teratomas originating from mouse embryonic stem cells. Am J Physiol Renal Physiol. 2006; 290: F52-60
|
|
|
|
|
|
19) Kobayashi T, Tanaka H, Kuwana H, et al. Wnt4-transformed mouse embryonic stem cells differentiate into renal tubular cells. Biochem Biophys Res Commun. 2005; 336: 3527-34
|
|
|
|
|
|
20) Vigneau C, Polgar K, Striker G, et al. Mouse embryonic stem cell-derived embryoid bodies generate progenitors that integrate long term into renal proximal tubules in vivo. J Am Soc Nephrol. 2007; 18: 1709-20
|
|
|
|
|
|
21) Bruce SJ, Rea RW, Steptoe AL, et al. In vitro differentiation of murine embryonic stem cells toward a renal lineage. Differentiation. 2007; 75: 337-49
|
|
|
|
|
|
22) Mae S, Shirasawa S, Yoshie S, et al. Combination of small molecules enhances differentiation of mouse embryonic stem cells into intermediate mesoderm through BMP7-positive cells. Biochem Biophys Res Commun. 2010; 393: 877-82
|
|
|
|
|
|
23) Schuldiner M, Yanuka O, Itskovitz-Eldor J, et al. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A. 2007; 97: 11307-12
|
|
|
|
|
|
24) Batchelder CA, Lee CI, Matsell DG, et al. Renal ontogeny in the rhesus monkey (Macaca mulatta) and directed differentiation of human embryonic stem cells towards kidney precursors. Differentiation. 2009; 78: 45-56
|
|
|
|
|
|
25) D'Amour KA, Bang AG, Eliazer S, et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol. 2006; 24: 1392-401
|
|
|
|
|
|
26) Kroon E, Martinson LA, Kadoya K, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol. 2008; 26: 443-52
|
|
|
|
|
|
27) Hay DC, Zhao D, Fletcher J, et al. Efficient differentiation of hepatocytes from human embryonic stem cells exhibiting markers recapitulating liver development in vitro. Stem Cells. 2008; 26: 894-902
|
|
|
|
|
|
28) Osafune K, Caron L, Borowiak M, et al. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol. 2008; 26: 313-5
|
|
|
|
|
|
29) Kim K, Doi A, Wen B, et al. Epigenetic memory in induced pluripotent stem cells. Nature. 2010 [epub ahead of print]
|
|
|
|
|
|
30) Polo JM, Liu S, Figueroa ME, et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol. 2010; 28: 848-55
|
|
|
|
|
|
31) Chen S, Borowiak M, Fox JL, et al. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nat Chem Biol. 2009; 5: 258-65
|
|
|
|
|
|
32) Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003; 302: 415-9
|
|
|
|
|
|
33) Lau F, Ahfeldt T, Osafune K, et al. Induced pluripotent stem (iPS) cells: an up-to-the-minute review. F1000 Biology Reports. 2009; 1: 84
|
|
|
|
|
|
34) Fusaki N, Ban H, Nishiyama A, et al. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci. 2009; 85: 348-62
|
|
|
|
|
35) Yamanaka S. A fresh look at iPS cells. Cell. 2009; 137: 13-7
|
|
|
|
|
|
36) Ebert AD, Yu J, Rose FF Jr, et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature. 2009; 457: 277-80
|
|
|
|
|
|
37) Lee G, Papapetrou EP, Kim H, et al. Modeling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature. 2009; 461: 402-6
|
|
|
|
|
|
38) Carvajal-Vergara X, Sevilla A, D'Souza SL, et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature. 2010; 465: 808-12
|
|
|
|
|
|
39) Raya A, Rodriguez-Piza I, Guenechea G, et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature. 2009; 460: 53-9
|
|
|
|
|
|
40) Asai Y, Tada M, Otsuji TG, et al. Combination of functional cardiomyocytes derived from human stem cells and a highly-efficient microelectrode array system: an ideal hybrid model assay for drug development. Curr Stem Cell Res Ther. 2010; 5: 227-32
|
|
|
|
|